Patent · US Active

Compositions and methods for vaccinating against HSV-2

US8852611B2 · kind B2 · utility

0Cited by
19References
6Claims
0Family size

Assignees

Inventors

Key dates

Filing dateAug 14, 2012
Grant dateOct 7, 2014
Priority date
Expiry dateAug 14, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2710/16634
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention relates to therapeutic compositions and methods for systemic immune activation which are effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in mammals. The methods are particularly effective for protecting mammals from herpes simplex virus.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.